全半球葡萄糖代谢比值在神经元网络联系障碍中的诊断表现:对阿尔茨海默病与轻度认知障碍的诊断意义
该研究对23例阿尔茨海默病(AD,n=15)或轻度认知障碍(MCI,n=8)患者及10例健康对照行FDG-PET/CT,计算全半球葡萄糖代谢比值(THGr)并构建网络联系障碍检测(NDT)。AD与MCI患者联系障碍更明显、THGr更低;NDT区分患者与健康人及AD与MCI时阳性预测值高,但阴性预测值中等或较低。
要点
- AD患者大脑及小脑联系障碍检出率分别为47%和0%,MCI与健康对照均为0%。
- AD、MCI、健康对照的大脑THGr中位数分别为0.68、0.86、0.95(p=0.04)。
- NDT阳性对AD或MCI的阳性预测值为100%,对健康脑的阴性预测值为86%。
核心结论
- AD或MCI患者较健康对照联系障碍更明显、半球葡萄糖代谢偏侧化且THGr更低。
- NDT可区分AD和MCI患者与健康人,以及AD与MCI患者,阳性预测值高而阴性预测值中等或较低。
- THGr可作为跨机构研究AD、MCI及其他脑疾病神经元网络联系障碍的简便指标。
研究设计与样本
- 研究纳入23例患者(平均年龄63.7岁,范围50-78,女性17例),其中AD 15例、MCI 8例,均为2014年六个月内诊断。
- 对照为10例神经健康个体(平均年龄62.5岁,范围43-75,女性5例)。
- 所有对象行FDG-PET/CT,由神经影像专家视觉评估联系障碍,计算THGr并以ROC曲线下面积生成NDT。
主要发现
- AD、MCI和健康对照组大脑联系障碍定性检出分别为7/15(47%)、0/8(0%)、0/10(0%)。
- 大脑THGr中位数在AD、MCI和健康对照组分别为0.68(范围0.43-0.99)、0.86(范围0.64-0.98)、0.95(范围0.65-1.00),p=0.04。
- 小脑THGr中位数在AD、MCI和健康对照组分别为0.70(范围0.18-0.98)、0.70(范围0.48-0.81)、0.84(范围0.75-0.96),p=0.0138。
- NDT阳性对AD或MCI存在的阳性预测值为100%,对健康脑的阴性预测值为86%。
- THGr在MCI与AD之间的诊断表现:对AD的阳性预测值为100%,对MCI的阴性预测值为42.9%。
关键数值与推荐
- 大脑THGr中位数:AD 0.68、MCI 0.86、健康对照0.95(p=0.04)。
- 小脑THGr中位数:AD 0.70、MCI 0.70、健康对照0.84(p=0.0138)。
- NDT阳性对AD或MCI的阳性预测值100%,对健康脑的阴性预测值86%。
- THGr区分AD与MCI时对AD的阳性预测值100%,对MCI的阴性预测值42.9%。
临床怎么用
- FDG-PET/CT计算THGr可辅助评估AD和MCI患者的神经元网络联系障碍。
- NDT阳性支持AD或MCI的诊断,但阴性结果不能排除MCI(阴性预测值42.9%)。
- THGr方法简便,可能适合跨机构研究联系障碍,但需结合视觉评估与临床。
局限性
- 样本量小(AD 15例、MCI 8例、健康对照10例),结果需更大样本验证。
- 联系障碍的定性评估依赖神经影像专家视觉判断,可能存在主观性。
- 研究仅纳入2014年六个月内诊断的患者,未报告随访或外部验证数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We tested the hypothesis that lateralized hemispheric glucose metabolism may have diagnostic implications in Alzheimer's disease (AD) and mild cognitive impairment (MCI). METHODS: We performed FDG-PET/CT in 23 patients (mean age 63.7 years, range 50-78, 17 females) diagnosed with AD (n = 15) or MCI (n = 8) during a six-month period in 2014. Ten neurologically healthy individuals (HIs) (mean age 62.5 years, range 43-75, 5 females) served as controls. A neuroimaging expert provided visual assessment of diaschisis. The total hemispheric glucose metabolism ratio (THGr) was calculated, and with area-under the curve of receiver operating characteristics (AUC-ROC) we generated a "Network Diaschisis Test (NDT)". RESULTS: The qualitative detection of cerebral (Ce) and cerebellar (Cb) diaschisis was 7/15 (47%), 0/8 (0%), and 0/10 (0%) in AD, MCI, and HI groups, respectively. Median cerebral THGr was 0.68 (range 0.43-0.99), 0.86 (range 0.64-0.98), and 0.95 (range 0.65-1.00) for AD, MCI, and HI groups, respectively (p = 0.04). Median cerebellar THGr was, respectively, 0.70 (range 0.18-0.98), 0.70 (range 0.48-0.81), and 0.84 (range 0.75-0.96) (p = 0.0138). A positive NDT yielded a positive predictive value of 100% for the presence of AD or MCI and a 86% negative predictive value for healthy brain. Moreover, the diagnostic manifestation of THGr between MCI and AD led to a positive predictive value of 100% for AD, but a negative predictive value of 42.9% for MCI. CONCLUSION: Patients with AD or MCI had more pronounced diaschisis, lateralized hemispheric glucose metabolism and lower THGr compared to healthy controls. The NDT distinguished AD and MCI patients from HIs, and AD from MCI patients with a high positive predictive value and moderate and low negative predictive values. THGr can be a straightforward source of investigating neuronal network diaschisis in AD and MCI and in other cerebral diseases, across institutions.
引用
- Segtnan EA, Majdi A, Constantinescu C, et al. Diagnostic manifestations of total hemispheric glucose metabolism ratio in neuronal network diaschisis: diagnostic implications in Alzheimer's disease and mild cognitive impairment. Eur J Nucl Med Mol Imaging. 2019. PMID: 30637500. doi:10.1007/s00259-018-4248-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。